Cargando…
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
BACKGROUND: Resistance to platinum-based chemotherapy remains a great challenge for ovarian cancer treatment. The human let-7 family contains 13 members located on nine different chromosomes, and most members have been implicated in the modulation of drug sensitivity in cancers. Our previous study s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379542/ https://www.ncbi.nlm.nih.gov/pubmed/28376831 http://dx.doi.org/10.1186/s13048-017-0321-8 |
_version_ | 1782519628065406976 |
---|---|
author | Xiao, Man Cai, Jing Cai, Liqiong Jia, Jinghui Xie, Lisha Zhu, Ying Huang, Bangxing Jin, Dongdong Wang, Zehua |
author_facet | Xiao, Man Cai, Jing Cai, Liqiong Jia, Jinghui Xie, Lisha Zhu, Ying Huang, Bangxing Jin, Dongdong Wang, Zehua |
author_sort | Xiao, Man |
collection | PubMed |
description | BACKGROUND: Resistance to platinum-based chemotherapy remains a great challenge for ovarian cancer treatment. The human let-7 family contains 13 members located on nine different chromosomes, and most members have been implicated in the modulation of drug sensitivity in cancers. Our previous study showed that deregulation of let-7e in epithelial ovarian cancer (EOC) promoted the development of resistance to cisplatin. In the present study, we aimed to investigate the underlying mechanism and further evaluate the clinical value of let-7e in predicting chemo-response and prognosis in EOC. RESULTS: In situ hybridization assays revealed a significantly decreased expression of let-7e in chemo-resistant EOC tissues compared with chemo-sensitive cases. Transfection with let-7e agomir sensitized EOC cells to cisplatin, down-regulated BRCA1 and Rad51 expression, and repressed the repair of cisplatin-induced DNA double strand break, while let-7e inhibitor exerted the opposite effects. In human EOC tissues, BRCA1 and Rad51 levels were increased in the chemo-resistant group compared with the sensitive group and were negatively correlated with let-7e. Low let-7e and high Rad51 were significantly associated with poor progression-free survival and overall survival and multivariate regression analyses showed that let-7e was an independent predictor for overall survival and chemotherapy response in EOC. Receiver operating characteristic analysis indicated that let-7e level was highly predictive of resistance to platinum-taxane chemotherapy with an area under the curve of 0.826. CONCLUSIONS: In EOC, low let-7e leads to activation of BRCA1 and Rad51 expression and subsequent enhancement of DSB repair, which in turn results in cisplatin-resistance. Let-7e is a potential predictor for survival and chemo-response in EOC and re-expression of let-7e might be an effective strategy for overcoming chemo-resistance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13048-017-0321-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5379542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53795422017-04-07 Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair Xiao, Man Cai, Jing Cai, Liqiong Jia, Jinghui Xie, Lisha Zhu, Ying Huang, Bangxing Jin, Dongdong Wang, Zehua J Ovarian Res Research BACKGROUND: Resistance to platinum-based chemotherapy remains a great challenge for ovarian cancer treatment. The human let-7 family contains 13 members located on nine different chromosomes, and most members have been implicated in the modulation of drug sensitivity in cancers. Our previous study showed that deregulation of let-7e in epithelial ovarian cancer (EOC) promoted the development of resistance to cisplatin. In the present study, we aimed to investigate the underlying mechanism and further evaluate the clinical value of let-7e in predicting chemo-response and prognosis in EOC. RESULTS: In situ hybridization assays revealed a significantly decreased expression of let-7e in chemo-resistant EOC tissues compared with chemo-sensitive cases. Transfection with let-7e agomir sensitized EOC cells to cisplatin, down-regulated BRCA1 and Rad51 expression, and repressed the repair of cisplatin-induced DNA double strand break, while let-7e inhibitor exerted the opposite effects. In human EOC tissues, BRCA1 and Rad51 levels were increased in the chemo-resistant group compared with the sensitive group and were negatively correlated with let-7e. Low let-7e and high Rad51 were significantly associated with poor progression-free survival and overall survival and multivariate regression analyses showed that let-7e was an independent predictor for overall survival and chemotherapy response in EOC. Receiver operating characteristic analysis indicated that let-7e level was highly predictive of resistance to platinum-taxane chemotherapy with an area under the curve of 0.826. CONCLUSIONS: In EOC, low let-7e leads to activation of BRCA1 and Rad51 expression and subsequent enhancement of DSB repair, which in turn results in cisplatin-resistance. Let-7e is a potential predictor for survival and chemo-response in EOC and re-expression of let-7e might be an effective strategy for overcoming chemo-resistance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13048-017-0321-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-04 /pmc/articles/PMC5379542/ /pubmed/28376831 http://dx.doi.org/10.1186/s13048-017-0321-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Xiao, Man Cai, Jing Cai, Liqiong Jia, Jinghui Xie, Lisha Zhu, Ying Huang, Bangxing Jin, Dongdong Wang, Zehua Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair |
title | Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair |
title_full | Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair |
title_fullStr | Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair |
title_full_unstemmed | Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair |
title_short | Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair |
title_sort | let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing dna double strand break repair |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379542/ https://www.ncbi.nlm.nih.gov/pubmed/28376831 http://dx.doi.org/10.1186/s13048-017-0321-8 |
work_keys_str_mv | AT xiaoman let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT caijing let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT cailiqiong let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT jiajinghui let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT xielisha let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT zhuying let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT huangbangxing let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT jindongdong let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair AT wangzehua let7esensitizesepithelialovariancancertocisplatinthroughrepressingdnadoublestrandbreakrepair |